Toggle Menu
Join our Community
Support ToI and remove
all
ads
Learn more
English
Français
עברית
Get The Daily Edition
Account
Sign In
Sign in
Join our Community
Open Search form
Toggle Menu
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Community
(members only)
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Open Search form
Toggle Menu
search
Input search
Clear search input
English
Français
עברית
Latest Articles
Latest Alerts
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Community
(members only)
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Community
Join our community
Sign in
About The Times of Israel
Advertise on The Times of Israel
Contact us
Download our App
For IOS users
For Android users
Get the Daily Edition
submit
Follow us
© 2026 The Times of Israel , All Rights Reserved
Terms and conditions
Privacy policy
Your Privacy Rights
Input search
Clear search input
Tech Israel
Daily Updates from Silicon Wadi for
Sunday, August 19, 2018
Facebook
Twitter
View previous edition
View next edition
Israeli OCD treatment gets FDA green light for US marketing
By
Shoshanna Solomon
Brainsway’s device, which magnetically stimulates nerve cells in the brain, said to provide patients with ‘another option’ when traditional treatment fails
Teva shares jump as drugmaker gets nod for generic version of allergy EpiPen
By
Shoshanna Solomon
Approval of emergency auto-injector comes after the Jerusalem-based drugmaker failed to get regulatory nod in 2016
Joint research
Weed firms fume as government rolls with cannabis research but stubs out exports
By
Melanie Lidman
The Volcani Center’s medical marijuana research is part of Israel’s bid to be a world leader in medical cannabis, though businesses are angry over Netanyahu’s exports freeze
Iran seeking to bypass US sanctions even if Europe doesn’t maintain oil ties
By
ToI Staff
and
AFP
Circumcising babies increases risk of cot death, contested new study suggests
By
JTA
Israel-born genetics scholar asserts trauma of procedure tied to prevalence of SIDS, though his claims are rejected as ‘nonsense’ by one pediatrician
Jonathan Sacks
To lead is to serve
The Torah is a sustained exploration of the extent to which a society can be organised not on the basis of power (Shoftim)
Israel’s newest doctors hope to make an impact on overburdened medical system
By
Luke Tress
Amid a shortage of medical professionals and resources, latest immigrants from North America are eager to help fill the gap
Tumors to meet a frozen end at private Haifa hospital
By
Shoshanna Solomon
IceCure’s tech to be used starting within a few months, initially on benign breast tumors and malignant kidney tumors
View Edition by Date
July
August 2018
September
Mo
Tu
We
Th
Fr
Sa
Su
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
The Times of Israel
TECH ISRAEL
FREE, DAILY TO YOUR INBOX
The email is either missing or invalid.
By signing up, you agree to our
terms
You hereby accept The Times of Israel
Terms of Use
and
Privacy Policy
, and you agree to receive the latest news & offers from The Times of Israel and its partners or ad sponsors.
Advertisement
Advertisement
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
Stay updated
No thanks
You're subscribed
close popup
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Email address
Please use the following structure: example@domain.com
REGISTER OR SIGN IN
Or Continue with
By registering you agree to the
terms and conditions
. Once registered, you’ll receive our Daily Edition email for free.
Send me The Times of Israel Daily Edition
back
close popup
Register to continue
Email address
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Register
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Continue
I forgot my password
/
Send me a sign in link
Or Continue with
back
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete your registration.